Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: Evaluation of both monitoring methods

Drug Testing and Analysis

Volumn 7, Issue 8, 2015, Pages 695-702

  Hoeke, Henrike ^a   Roeder, Stefan ^b   Bertsche, Thilo ^a   Lehmann, Irina ^b   Borte, Michael ^a   von Bergen, Martin ^b,c   Wissenbach, Dirk K ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Drug monitoring; Exposome; LC MS MS; Pregnancy; Screening

Indexed keywords

DIAGNOSIS; DIETARY SUPPLEMENTS; DISEASES; DRUG PRODUCTS; HEALTH RISKS; MASS SPECTROMETRY; OBSTETRICS; PATIENT MONITORING;

BIOMONITORING; CHRONIC DISEASE; DISEASE RISKS; DRUG MONITORING; ENVIRONMENTAL RISK FACTOR; EXPOSOME; LC-MS-MS; LC.MS/MS; MONITORING METHODS; PREGNANCY;

LIQUID CHROMATOGRAPHY;

AMBROXOL; AMPICILLIN; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BISOPROLOL; CETIRIZINE; CINCHOCAINE; CITALOPRAM; CLARITHROMYCIN; CLEMASTINE; CLINDAMYCIN; CLOTRIMAZOLE; DIMETINDENE; DIPHENHYDRAMINE; HYDROXYZINE; IBUPROFEN; LAMOTRIGINE; LIDOCAINE; LOPERAMIDE; METHYLDOPA; MICONAZOLE; OXYMETAZOLINE; PARACETAMOL; PENTOXYVERINE; PROMETHAZINE; XYLOMETAZOLINE; DRUG;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MONITORING; DRUG USE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MASS SPECTROMETRY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; THIRD TRIMESTER PREGNANCY; URINALYSIS; EVALUATION STUDY; PREGNANCY; PROCEDURES; TANDEM MASS SPECTROMETRY; URINE;

ANALGESICS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; FEMALE; HUMANS; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84938949268     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1767     Document Type: Article

References (44)

1. F.S. Collins . The case for a US prospective cohort study of genes and environment. Nature 2004, 429, 475.
2. C.P. Wild . Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005, 14, 1847.
3. S.M. Rappaport, M.T. Smith . Epidemiology. Environment and disease risks. Science 2010, 330, 460.
4. C.P. Wild . The exposome: From concept to utility. Int. J. Epidemiol. 2012, 41, 24.
5. P.J. Lioy, S.M. Rappaport . Exposure science and the exposome: An opportunity for coherence in the environmental health sciences. Environ. Health Persp. 2011, 119, A466.
6. S.M. Rappaport . Implications of the exposome for exposure science. J. Expo. Sci. Env. Epid. 2011, 21, 5.
7. R.C. Baselt . Disposition of Toxic Drugs and Chemicals in Man, 9th ed., Biomedical Publications, Seal Beach, Ca., 2011.
8. H.H. Maurer . What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? J. Chromatogr. A 2013, 1292, 19.
9. M. Thevis, A. Thomas, V. Pop, W. Schanzer . Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: Possibilities and limitations. J. Chromatogr. A 2013, 1292, 38.
10. P. Clarke, N. Sastry, D. Duffy, J. Ailshire . Accuracy of self-reported versus measured weight over adolescence and young adulthood: Findings from the national longitudinal study of adolescent health, 1996-2008. Am. J. Epidemiol. 2014, 180, 153.
11. A.A. Mitchell, L.B. Cottler, S. Shapiro . Effect of questionnaire design on recall of drug exposure in pregnancy. Am. J. Epidemiol. 1986, 123, 670.
12. A.L. Flak, S. Su, J. Bertrand, C.H. Denny, U.S. Kesmodel, M.E. Cogswell . The association of mild, moderate, and binge prenatal alcohol exposure and child neuropsychological outcomes: A meta-analysis. Alcohol. Clin. Exp. Res. 2014, 38, 214.
13. P. Grandjean, P. Weihe, R.F. White, F. Debes, S. Araki, K. Yokoyama, K. Murata, N. Sorensen, R. Dahl, P.J. Jorgensen . Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol. Teratol. 1997, 19, 417.
14. C. Rebordosa, M. Kogevinas, H.T. Sorensen, J. Olsen . Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: A birth cohort study. Int. J. Epidemiol. 2008, 37, 583.
15. M.T. Smith, L. Zhang, C.M. McHale, C.F. Skibola, S.M. Rappaport . Benzene, the exposome and future investigations of leukemia etiology. Chem.-Biol. Interact. 2011, 192, 155.
16. D. Hinz, M. Bauer, S. Roder, S. Olek, J. Huehn, U. Sack, M. Borte, J.C. Simon, I. Lehmann, G. Herberth, LINAstudy group. Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year. Allergy 2012, 67, 380.
17. G. Herberth, M. Bauer, M. Gasch, D. Hinz, S. Roder, S. Olek, T. Kohajda, U. Rolle-Kampczyk, M. von Bergen, U. Sack, M. Borte, I. Lehmann, Lifestyle and Environmental Factors and their Influence on Newborns Allergy Risk study group. Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers. J. Allergy Clin. Immunol. 2014, 133, 543.
18. K. Weisse, I. Lehmann, D. Heroux, T. Kohajda, G. Herberth, S. Roder, M. von Bergen, M. Borte, J. Denburg . The LINA cohort: indoor chemical exposure, circulating eosinophil/basophil (Eo/B) progenitors and early life skin manifestations. Clin. Exp. Allergy 2012, 42, 1337.
19. K.M. Junge, F. Hornig, G. Herberth, S. Roder, T. Kohajda, U. Rolle-Kampczyk, M. von Bergen, M. Borte, J.C. Simon, D. Heroux, J.A. Denburg, I. Lehmann . The LINA cohort: Cord blood eosinophil/basophil progenitors predict respiratory outcomes in early infancy. Clin. Immunol. 2014, 152, 68.
20. U. Franck, A. Weller, S.W. Roder, G. Herberth, K.M. Junge, T. Kohajda, M. von Bergen, U. Rolle-Kampczyk, U. Diez, M. Borte, I. Lehmann, N.A.S.G. Li . Prenatal VOC exposure and redecoration are related to wheezing in early infancy. Environ. Int. 2014, 73, 393.
21. K. Weisse, S. Winkler, F. Hirche, G. Herberth, D. Hinz, M. Bauer, S. Roder, U. Rolle-Kampczyk, M. von Bergen, S. Olek, U. Sack, T. Richter, U. Diez, M. Borte, G.I. Stangl, I. Lehmann . Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy 2013, 68, 220.
22. S.O. Shaheen, R.B. Newson, A.J. Henderson, J.E. Headley, F.D. Stratton, R.W. Jones, D.P. Strachan, A.S. Team . Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin. Exp. Allergy 2005, 35, 18.
23. A. Schoenfeld, Y. Bar, P. Merlob, Y. Ovadia . NSAIDs: Maternal and fetal considerations. Am. J. Reprod. Immunol. 1992, 28, 141.
24. D.K. Wissenbach, M.R. Meyer, D. Remane, A.A. Weber, H.H. Maurer . Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants. Anal. Bioanal. Chem. 2011, 400, 79.
25. H.H. Maurer, D.K. Wissenbach, A.A. Weber . Maurer/Wissenbach/Weber LC-MSn Library of Drugs, Poisons, and Their Metabolites. Wiley, Weinheim, 2014.
26. D.K. Wissenbach, M.R. Meyer, D. Remane, A.A. Philipp, A.A. Weber, H.H. Maurer . Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept. Anal. Bioanal. Chem. 2011, 400, 3481.
27. D.K. Wissenbach, M.R. Meyer, A.A. Weber, D. Remane, A.H. Ewald, F.T. Peters, H.H. Maurer . Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument? J. Mass Spectrom. 2012, 47, 66.
28. G.M. Meyer, M.R. Meyer, D.K. Wissenbach, H.H. Maurer . Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MS(n) and LC-high-resolution MS(n). J. Mass Spectrom. 2013, 48, 24.
29. C.S. Wink, G.M. Meyer, D.K. Wissenbach, A. Jacobsen-Bauer, M.R. Meyer, H.H. Maurer . Lefetamine-derived designer drugs N-ethyl-1, 2-diphenylethylamine (NEDPA) and N-iso-propyl-1, 2-diphenylethylamine (NPDPA): Metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS. Drug testing and analysis, 6, 2014; 1038-1048.
30. R.J. Coppin, D.M. Wicke, P.S. Little . Managing nocturnal leg cramps--calf-stretching exercises and cessation of quinine treatment: A factorial randomised controlled trial. Brit. J. Gen. Pract. 2005, 55, 186.
31. A.F. da Silva, J.L. Benchimol . Malaria and quinine resistance: A medical and scientific issue between Brazil and Germany (1907-19). Med. Hist. 2014, 58, 1.
32. R.M. Chico, D. Chandramohan . Quinine for the treatment of malaria in pregnancy. Lancet 2010, 10, 140.
33. R. McGready, K.L. Thwai, T. Cho, Samuel, S. Looareesuwan, N.J. White, F. Nosten . The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. T. Roy. Soc. Trop. Med. H. 2002, 96, 180.
34. J.C. Reijenga, G.V. Aben, A.A. Lemmens, T.P. Verheggen, C.H. de Bruijn, F.M. Everaerts . Determination of quinine in beverages, pharmaceutical preparations and urine by isotachophoresis. J. Chromatogr. 1985, 320, 245.
35. P.J. Barnes . Theophylline. Am. J. Resp. Crit. Care 2013, 188, 901.
36. A. Erebara, P. Bozzo, A. Einarson, G. Koren . Treating the common cold during pregnancy. Can. Fam. Physician 2008, 54, 687.
37. Z. Kazy, E. Puho, A.E. Czeizel . Effect of vaginal metronidazole + miconazole treatment during pregnancy for gestational age and birth weight in a population-based study. Arch. Gynecol. Obstet. 2005, 272, 294.
38. D.M. Wood, E. English, S. Butt, H. Ovaska, F. Garnham, P.I. Dargan . Patient knowledge of the paracetamol content of over-the-counter (OTC) analgesics, cough/cold remedies and prescription medications. Emerg. Med. J. 2010, 27, 829.
39. R.L. Loo, Q. Chan, I.J. Brown, C.E. Robertson, J. Stamler, J.K. Nicholson, E. Holmes, P. Elliott, I.R. Group . A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: The INTERMAP Study. Am. J. Epidemiol. 2012, 175, 348.
40. A. Bondesson, L. Hellstrom, T. Eriksson, P. Hoglund . A structured questionnaire to assess patient compliance and beliefs about medicines taking into account the ordered categorical structure of data. J. Eval. Clin. Pract. 2009, 15, 713.
41. K.M. Walewski, L. Cicutto, A.D. D'Urzo, R.J. Heslegrave, K.R. Chapman . Evaluation of a questionnaire to assess compliance with anti-asthma medications. J. Asthma 2004, 41, 77.
42. T.C. Kwong, D. Shearer . Detection of drug use during pregnancy. Obstet. Gyn. Clin. N Am. 1998, 25, 43.
43. W.E. Wingert, M.S. Feldman, M.H. Kim, L. Noble, I. Hand, J.J. Yoon . A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug-use during pregnancy. J. Forensic Sci. 1994, 39, 150.
44. B.M. Lester, M. ElSohly, L.L. Wright, V.L. Smeriglio, J. Verter, C.R. Bauer, S. Shankaran, H.S. Bada, H.H. Walls, M.A. Huestis, L.P. Finnegan, P.L. Maza . The maternal lifestyle study: Drug use by meconium toxicology and maternal self-report. Pediatrics 2001, 107, 309.